Software firm Instem Life Science Systems has won a £685,000 contract to supply to a pharmaceutical firm.
Staffordshire-based Instem (INS) has won a four-year contract with one of the five largest pharmaceutical organisations for its Provantis solution suite.
The news came after the company revealed a rise in first half profits.
Chief executive Phil Reason said: “We are delighted to have contracted additional Provantis modules to such a prestigious top five pharmaceutical company, and it is testament to our quality offering that we have replaced their incumbent system. It is a continuing trend in the industry that large pharma are consolidating their IT systems and vendors as the cost of research and development rises.”
Pre-tax profits at the company rose to £294,000 in the six months to the end of June, up from £204,000 in the same period last year.
Revenues from its core business were lower than a year ago due, in part, to a major customer project having being delivered in that half year.
